EW — Edwards Lifesciences Share News
0.000.00%
Last trade - 00:00- $54.44bn
- $50.89bn
- $6.07bn
FDA flags Edwards heart-valve delivery system issue after death, injury
Brief: FDA Aware Edwards Lifesciences Issued Letter Recommending Some Delivery Systems Used For Sapien M3 Transcatheter Mitral Valve Replacement Be Removed
Brief: Edwards Lifesciences Corporation - Maintains Confidence In Financial Guidance For 2026
U.S. RESEARCH ROUNDUP-Deckers Brands, Rollins, United Rentals
Edwards Lifesciences Corp reports results for the quarter ended June 30 - Earnings Summary
Edwards Lifesciences beats quarterly estimates on strong demand for heart devices
Edwards Lifesciences Q2 sales beat estimates, supported by sustained clinical momentum; shares up
Abbott raises 2026 profit forecast on strength in diagnostics, medical devices (updated)
Abbott raises 2026 profit forecast on heart device strength
Analysts see risks for elective-procedure medtechs after HCA cuts profit forecast
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
Brief: Edwards Lifesciences Announces Appointment Of CFO
Health Rounds: New CAR-T cell method may allow some cancer patients to skip chemotherapy
Live Markets: US stocks rise on Iran hopes, earnings boost
U.S. RESEARCH ROUNDUP-Elevance Health, Huntington Bancshares, Monolithic Power Systems
Edwards Lifesciences beats quarterly estimates on robust demand for artificial heart valves
Edwards Lifesciences Q1 sales rise 16.7%, beat estimates
Brief: Edwards Lifesciences Q1 Adjusted EPS USD 0.78 Vs. IBES Estimate USD 0.73
What to Watch in the Day Ahead - Thursday, April 23